CAM
EIGR

Cormorant Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Cormorant Asset Management’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
2021
Q2 		$2.43M Sell
2021
Q1 		$3.54M Hold
2020
Q4 		$4.92M Sell
2020
Q3 		$3.66M Sell
2020
Q2 		$6.72M Sell
2020
Q1 		$5.54M Sell
2019
Q4 		$12.4M Sell
2019
Q3 		$10.2M Sell
2019
Q2 		$12.2M Buy